Abstract
Placental mesenchymal dysplasia (PMD) is a rare placental anomaly. The reported incidence of PMD is 0.02%, although the real frequency might be underestimated. PMD is often misdiagnosed with hydatiform mole (HM) [1–3] because of the similar sonographic findings shared by the two entities [4]. Trophoblastic hyperplasia, which is typical of HM, is always absent in PMD, but consistent diagnostic criteria for PMD are not yet established [5]. PMD is often associated to genetic syndromes. Even in case of a normal karyotype, PMD has been related with intrauterine growth restriction (IUGR) and fetal demise [6].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Obstetrics & Gynecology and Reproductive Biology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
